Viscofan agrees to acquire 85% stake in Shandong Haiaos Biotechnology

Viscofan Group has reached an agreement in principle to acquire up to 85% of China-based collagen-casing producer Shandong Haiaos Biotechnology through its Suzhou subsidiary. The deal is valued against a €133 million enterprise value, with Haiaos generating approximately €57.5 million in revenue and €16.5 million in EBITDA in 2025.

“The proposed acquisition, valued against a €133 million enterprise value, would combine Haiaos’ local capabilities with Viscofan’s expertise, expanding production capacity and strengthening its regional presence.”tipranks.com

• 2 sources
• tipranks.comViscofan Agrees in Principle to Acquire Majority Stake in Haiaos - TipRanks.comNov 6, 2026
• en.empresaexterior.comViscofan acquires China's Haiaos: key aspects of the Asia-Pacific operation -Digital Editorial Team eENov 7, 2026

Summarized from public sources; check the original articles before acting on it.